EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudie

Effectiveness of Nonpharmacologic Treatments for Chronic Low Back Pain

Julie M Fritz iD, Richard L Skolasky iD, Gerard Brennan iD, Kate Minick iD, Stephen T Wegener, Elizabeth Lane iD, Eric L Garland, Rachel V Aaron, Tyler Bardsley, Nora Fino, Yidan Zhang, Jincheng Shen iD und 8 weitere

Annals of Internal Medicine · 2026

DOI: 10.7326/annals-25-04645 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Internal Medicine, 2026. Verfasst von Julie M Fritz und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy and Athletic Training, College of Health, University of Utah, Salt Lake City, Utah (J.M.F., E.L., A.T.). Hauptthemen laut MEDLINE: Low Back Pain, Cognitive Behavioral Therapy, Chronic Pain, Physical Therapy Modalities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Many treatments are recommended for chronic low back pain (cLBP), but comparative effectiveness and adaptive interventions have not been adequately studied. OBJECTIVE: To compare the effectiveness of physical therapy (PT) and cognitive behavioral therapy (CBT) as first-stage treatment and switching treatments versus mindfulness as second-stage treatment. DESIGN: Multisite sequential, multiple-assignment, randomized trial with 52-week follow-up. (ClinicalTrials.gov: NCT03859713). SETTING: Three health care systems. PARTICIPANTS: Adults with cLBP. INTERVENTION: Eight weeks of PT or CBT in stage I. Nonresponders were randomly assigned again to 8 weeks of stage II treatment. MEASUREMENTS: Co-primary outcomes were function measured with the Oswestry Disability Index (ODI; range, 0 to 100) and pain intensity (range, 0 to 10) at 10 (stage I), 26, and 52 (stage II) weeks. RESULTS: The sample comprised 749 participants. After 10 weeks, there was greater improvement in function in the PT group (adjusted mean ODI difference, 2.8 [96% CI, 0.38 to 5.1]) and no difference in pain intensity (adjusted mean difference, 0.32 [99% CI, -0.07 to 0.71]). The mean difference in ODI was below the minimum important difference of 6. After 52 weeks, there were no differences in stage II treatments for nonresponders for either function (adjusted mean ODI difference, 0.43 [96% CI, -0.29 to 2.4]) or pain intensity (adjusted mean difference, -0.05 [96% CI, -0.58 to 0.48]). LIMITATIONS: Treatment initiation was lower than expected, particularly for CBT and for nonresponders. Participants were not blinded. Sample size was reduced due to the COVID-19 pandemic. CONCLUSION: Patients with cLBP may benefit from PT as first-line treatment. Among nonresponders, there were no differences in second-stage treatment with mindfulness or switching. PRIMARY FUNDING SOURCE: Patient-Centered Outcomes Research Institute (PCORI).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Low Back PainCognitive Behavioral TherapyChronic PainPhysical Therapy ModalitiesMindfulnessHumansFemaleMiddle AgedMaleAdultTreatment OutcomePain MeasurementDisability Evaluation

Autor:innen und Institutionen

  • Department of Physical Therapy and Athletic Training, College of Health, University of Utah, Salt Lake City, Utah (J.M.F., E.L., A.T.).
  • Department of Orthopaedic Surgery and Department of Physical Medicine and Rehabilitation, The Johns Hopkins University School of Medicine, Baltimore, Maryland (R.L.S.).
  • Rehabilitation Services, Intermountain Health, Salt Lake City, Utah (G.B., K.M., S.H.).
  • Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland (S.T.W.).
  • Department of Psychiatry and Sanford Institute for Empathy and Compassion, University of California San Diego, La Jolla, California (E.L.G.).
  • Department of Physical Medicine and Rehabilitation, The Johns Hopkins University School of Medicine, Baltimore, Maryland (R.V.A., F.S.R., K.M.).

ORCID-Profile: Julie M Fritz, Richard L Skolasky, Gerard Brennan, Kate Minick, Elizabeth Lane, Jincheng Shen, Kevin McLaughlin

Zitieren

APA

Fritz, J. M., Skolasky, R. L., Brennan, G., Minick, K., Wegener, S. T., Lane, E., Garland, E. L., Aaron, R. V., Bardsley, T., Fino, N., Zhang, Y., Shen, J., Conroy, M. B., Hunter, S., Hanley, A., Thackeray, A., Rassu, F. S., McLaughlin, K., Cook, D., & Greene, T. (2026). Effectiveness of Nonpharmacologic Treatments for Chronic Low Back Pain. Annals of Internal Medicine. https://doi.org/10.7326/annals-25-04645

Vancouver

Fritz JM, Skolasky RL, Brennan G, Minick K, Wegener ST, Lane E, et al. Effectiveness of Nonpharmacologic Treatments for Chronic Low Back Pain. Annals of Internal Medicine. 2026. doi:10.7326/annals-25-04645

BibTeX
@article{Fritz2026,
  author = {Fritz, Julie M and Skolasky, Richard L and Brennan, Gerard and Minick, Kate and Wegener, Stephen T and Lane, Elizabeth and Garland, Eric L and Aaron, Rachel V and Bardsley, Tyler and Fino, Nora and Zhang, Yidan and Shen, Jincheng and Conroy, Molly B and Hunter, Stephen and Hanley, Adam and Thackeray, Anne and Rassu, Fenan S and McLaughlin, Kevin and Cook, Danielle and Greene, Tom},
  title = {Effectiveness of Nonpharmacologic Treatments for Chronic Low Back Pain},
  journal = {Annals of Internal Medicine},
  year = {2026},
  doi = {10.7326/annals-25-04645}
}
Kostenlos starten →